Crockett Thomas Andrew

CIK 00016909201 companySALISBURY, WILTSHIRE, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001690920

Recent Transactions

50 trades

Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-02-20$14.11/sh−24,888→ 211,203 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Units
2024-02-17−20,833→ 20,834 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-02-17+54,415→ 236,091 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-02-17−6,944→ 48,612 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Units
2024-02-17−20,833→ 62,500 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-02-17−5,805→ 52,245 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-02-14$15.01/sh−58,356→ 181,676 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Units
2024-02-11+83,333→ 83,333 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-02-11+122,500→ 240,032 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-02-01$16.18/sh−9,300→ 118,232 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-02-01$16.81/sh−700→ 117,532 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-12-27$12.02/sh−30,000→ 127,532 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-11-20$8.23/sh−14,807→ 157,532 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Unit
2023-11-17−20,833→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-11-17−5,805→ 58,050 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-11-17+33,583→ 172,339 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-11-17−6,945→ 55,556 total
Gift
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-10-30−8,000→ 138,756 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-08-18$10.73/sh−14,876→ 146,756 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-08-17−6,944→ 62,501 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-08-17−5,805→ 63,855 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Unit
2023-08-17−20,833→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-08-17+33,582→ 161,632 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-05-18$10.14/sh−5,627→ 128,050 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-05-17−5,805→ 69,660 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-05-17−6,945→ 69,445 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-05-17+12,750→ 133,677 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-02-17+12,749→ 127,627 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-02-17$7.66/sh−6,700→ 120,927 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-02-17−6,944→ 76,390 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-02-17−5,805→ 75,465 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Restricted Stock Unit
2023-02-17+6,944→ 0 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-01-11+83,334→ 83,334 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2022-11-18$5.44/sh−1,785→ 114,878 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2022-11-17−5,805→ 81,270 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2022-11-17+5,805→ 116,663 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2022-09-02$17.01/sh−1,320→ 110,858 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2022-08-17+5,805→ 113,975 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2022-08-17$14.96/sh−1,797→ 112,178 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2022-08-17−5,805→ 91,083 total
Gift
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2022-07-02−6,500→ 112,178 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Employee Stock Option (Right to Buy)
2022-05-17+61,920→ 61,920 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Units
2022-05-17+92,880→ 92,880 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2022-03-09$17.07/sh−10,000→ 114,670 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2021-10-01$17.18/sh−10,000→ 124,670 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2021-07-01$24.35/sh−5,650→ 134,670 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2021-07-01$23.88/sh−4,350→ 140,320 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2021-06-17$30.04/sh−1,067→ 144,670 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2021-06-09$30.05/sh−8,933→ 145,737 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Employee Stock Option (Right to Buy)
2021-05-26+200,000→ 200,000 total

Companies

KalVista Pharmaceuticals, Inc.
Director, President and CEO
$KALV

Recent Filings

Address

C/O KALVISTA PHARMACEUTICALS, INC. BUILDING 227, TETRICUS SCIENCE PARK, POR

SALISBURY, WILTSHIRE, X0, SP4 0JQ

View on SEC.gov